BSE Live
Nov 04, 16:01Prev. Close
432.05
Open Price
429.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 04, 15:52Prev. Close
431.85
Open Price
430.00
Bid Price (Qty.)
432.30 (116)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Panacea Biotec (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -1.37 | -0.19 | -5.43 | 175.98 | -24.11 | |
| Diluted EPS (Rs.) | -1.37 | -0.19 | -5.43 | 175.98 | -24.11 | |
| Cash EPS (Rs.) | 4.26 | 5.75 | 0.88 | 183.11 | -16.68 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 136.18 | 133.94 | 133.63 | 138.09 | -41.36 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 136.18 | 133.94 | 133.63 | 138.09 | -41.36 | |
| Revenue from Operations/Share (Rs.) | 91.21 | 91.29 | 75.09 | 107.96 | 102.01 | |
| PBDIT/Share (Rs.) | -0.86 | 0.94 | -7.56 | -0.47 | 14.14 | |
| PBIT/Share (Rs.) | -6.54 | -5.06 | -13.95 | -7.60 | 6.70 | |
| PBT/Share (Rs.) | -1.30 | 0.24 | 2.09 | 236.54 | -23.56 | |
| Net Profit/Share (Rs.) | -1.42 | -0.25 | -5.51 | 175.98 | -24.12 | |
| NP After MI And SOA / Share (Rs.) | -1.37 | -0.19 | -5.43 | 175.98 | -24.11 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -0.93 | 1.02 | -10.06 | -0.43 | 13.86 | |
| PBIT Margin (%) | -7.16 | -5.53 | -18.57 | -7.04 | 6.56 | |
| PBT Margin (%) | -1.42 | 0.26 | 2.78 | 219.10 | -23.09 | |
| Net Profit Margin (%) | -1.55 | -0.26 | -7.33 | 163.01 | -23.64 | |
| NP After MI And SOA Margin (%) | -1.49 | -0.20 | -7.22 | 163.01 | -23.63 | |
| Return on Networth/Equity (%) | -1.00 | -0.14 | -4.04 | 126.99 | 0.00 | |
| Return on Capital Employed (%) | -4.34 | -3.32 | -9.09 | -4.75 | 5.44 | |
| Return on Assets (%) | -0.64 | -0.09 | -2.61 | 60.47 | -12.52 | |
| Total Debt/Equity (X) | 0.03 | 0.02 | 0.02 | 0.04 | -2.92 | |
| Asset Turnover Ratio (%) | 0.44 | 0.45 | 0.30 | 0.24 | 53.00 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.49 | 1.57 | 1.71 | 1.30 | 1.20 | |
| Quick Ratio (X) | 0.90 | 0.99 | 1.10 | 1.03 | 0.79 | |
| Inventory Turnover Ratio (X) | 1.09 | 1.11 | 1.02 | 1.14 | 3.59 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | -1.35 | 1.60 | -10.43 | -0.02 | 0.22 | |
| Interest Coverage Ratios (Post Tax) (%) | -1.35 | 1.60 | -10.43 | -0.02 | 0.22 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 2,612.25 | 620.65 | 454.38 | 355.93 | 1,682.86 | |
| EV/Net Operating Revenue (X) | 4.67 | 1.11 | 0.99 | 0.54 | 2.69 | |
| EV/EBITDA (X) | -497.57 | 108.22 | -9.81 | -122.86 | 19.43 | |
| MarketCap/Net Operating Revenue (X) | 4.83 | 1.33 | 1.44 | 1.37 | 1.74 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 3.24 | 0.91 | 0.81 | 1.07 | -4.34 | |
| Price/Net Operating Revenue | 4.83 | 1.33 | 1.44 | 1.37 | 1.74 | |
| Earnings Yield | 0.00 | 0.00 | -0.05 | 1.19 | -0.14 |
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
24.04.2025
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
28.11.2024
Panacea Biotec Consolidated September 2024 Net Sales at Rs 147.35 crore, up 3.03% Y-o-Y